Emerging Landscape of Nanobodies and Their Neutralizing Applications against SARS-CoV-2 Virus

被引:10
|
作者
Feng, Xuemei [1 ]
Wang, Hu [1 ,2 ]
机构
[1] China Three Gorges Univ, Coll Med & Hlth Sci, Dept Microbiol & Immunol, Yichang 443002, Peoples R China
[2] Johns Hopkins Univ, Inst Cell Engn, Sch Med, Baltimore, MD 21215 USA
关键词
COVID-19; SARS-CoV-2; nanobodies; neutralization; target; detection; SINGLE-DOMAIN ANTIBODY; PHAGE-DISPLAY; STRATEGIES; LIBRARY; PROTEIN;
D O I
10.1021/acsptsci.3c00042
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The new severe acute respiratorysyndrome coronavirus 2 (SARS-CoV-2)that causes the coronavirus disease 2019 (COVID-19) has significantlyaltered people's way of life. Despite widespread knowledgeof vaccination, mask use, and avoidance of close contact, COVID-19is still spreading around the world. Numerous research teams are examiningthe SARS-CoV-2 infection process to discover strategies to identify,prevent, and treat COVID-19 to limit the spread of this chronic coronavirusillness and restore lives to normalcy. Nanobodies have advantagesover polyclonal and monoclonal antibodies (Ab) and Ab fragments, includingreduced size, high stability, simplicity in manufacture, compatibilitywith genetic engineering methods, and lack of solubility and aggregationissues. Recent studies have shown that nanobodies that target theSARS-CoV-2 receptor-binding domain and disrupt ACE2 interactions arehelpful in the prevention and treatment of SARS-CoV-2-infected animalmodels, despite the lack of evidence in human patients. The creationand evaluation of nanobodies, as well as their diagnostic and therapeuticapplications against COVID-19, are discussed in this paper.
引用
收藏
页码:925 / 942
页数:18
相关论文
共 50 条
  • [21] Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
    Wei-Hung Chen
    Agnes Hajduczki
    Elizabeth J. Martinez
    Hongjun Bai
    Hanover Matz
    Thomas M. Hill
    Eric Lewitus
    William C. Chang
    Layla Dawit
    Caroline E. Peterson
    Phyllis A. Rees
    Adelola B. Ajayi
    Emily S. Golub
    Isabella Swafford
    Vincent Dussupt
    Sapna David
    Sandra V. Mayer
    Sandrine Soman
    Caitlin Kuklis
    Courtney Corbitt
    Jocelyn King
    Misook Choe
    Rajeshwer S. Sankhala
    Paul V. Thomas
    Michelle Zemil
    Lindsay Wieczorek
    Tricia Hart
    Debora Duso
    Larry Kummer
    Lianying Yan
    Spencer L. Sterling
    Eric D. Laing
    Christopher C. Broder
    Jazmean K. Williams
    Edgar Davidson
    Benjamin J. Doranz
    Shelly J. Krebs
    Victoria R. Polonis
    Dominic Paquin-Proulx
    Morgane Rolland
    William W. Reiley
    Gregory D. Gromowski
    Kayvon Modjarrad
    Helen Dooley
    M. Gordon Joyce
    Nature Communications, 14
  • [22] NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodies
    Wagner, Teresa R.
    Ostertag, Elena
    Kaiser, Philipp D.
    Gramlich, Marius
    Ruetalo, Natalia
    Junker, Daniel
    Haering, Julia
    Traenkle, Bjoern
    Becker, Matthias
    Dulovic, Alex
    Schweizer, Helen
    Nueske, Stefan
    Scholz, Armin
    Zeck, Anne
    Schenke-Layland, Katja
    Nelde, Annika
    Strengert, Monika
    Walz, Juliane S.
    Zocher, Georg
    Stehle, Thilo
    Schindler, Michael
    Schneiderhan-Marra, Nicole
    Rothbauer, Ulrich
    EMBO REPORTS, 2021, 22 (05)
  • [23] Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
    Chen, Wei-Hung
    Hajduczki, Agnes
    Martinez, Elizabeth J.
    Bai, Hongjun
    Matz, Hanover
    Hill, Thomas M.
    Lewitus, Eric
    Chang, William C.
    Dawit, Layla
    Peterson, Caroline E.
    Rees, Phyllis A.
    Ajayi, Adelola B.
    Golub, Emily S.
    Swafford, Isabella
    Dussupt, Vincent
    David, Sapna
    Mayer, Sandra V.
    Soman, Sandrine
    Kuklis, Caitlin
    Corbitt, Courtney
    King, Jocelyn
    Choe, Misook
    Sankhala, Rajeshwer S.
    Thomas, Paul V.
    Zemil, Michelle
    Wieczorek, Lindsay
    Hart, Tricia
    Duso, Debora
    Kummer, Larry
    Yan, Lianying
    Sterling, Spencer L.
    Laing, Eric D.
    Broder, Christopher C.
    Williams, Jazmean K.
    Davidson, Edgar
    Doranz, Benjamin J.
    Krebs, Shelly J.
    Polonis, Victoria R.
    Paquin-Proulx, Dominic
    Rolland, Morgane
    Reiley, William W.
    Gromowski, Gregory D.
    Modjarrad, Kayvon
    Dooley, Helen
    Joyce, M. Gordon
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [24] Applications of nanobodies in the prevention, detection, and treatment of the evolving SARS-CoV-2
    Wang, Wenyi
    Hu, Yue
    Li, Bohan
    Wang, Huanan
    Shen, Jinhua
    BIOCHEMICAL PHARMACOLOGY, 2023, 208
  • [25] A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern
    Parray, Hilal Ahmad
    Narayanan, Naveen
    Garg, Sonal
    Rizvi, Zaigham Abbas
    Shrivastava, Tripti
    Kushwaha, Sachin
    Singh, Janmejay
    Murugavelu, Praveenkumar
    Anantharaj, Anbalagan
    Mehdi, Farha
    Raj, Nisha
    Singh, Shivam
    Dandotiya, Jyotsna
    Lukose, Asha
    Jamwal, Deepti
    Kumar, Sandeep
    Chiranjivi, Adarsh K.
    Dhyani, Samridhi
    Mishra, Nitesh
    Kumar, Sanjeev
    Jakhar, Kamini
    Sonar, Sudipta
    Panchal, Anil Kumar
    Tripathy, Manas Ranjan
    Chowdhury, Shirlie Roy
    Ahmed, Shubbir
    Samal, Sweety
    Mani, Shailendra
    Bhattacharyya, Sankar
    Das, Supratik
    Sinha, Subrata
    Luthra, Kalpana
    Batra, Gaurav
    Sehgal, Devinder
    Medigeshi, Guruprasad R.
    Sharma, Chandresh
    Awasthi, Amit
    Garg, Pramod Kumar
    Nair, Deepak T.
    Kumar, Rajesh
    PLOS PATHOGENS, 2022, 18 (12)
  • [26] Broadly neutralizing antibodies against SARS-CoV-2 variants
    Linqi Zhang
    NationalScienceOpen, 2022, 1 (01) : 24 - 31
  • [27] Duration of SARS-CoV-2 Serum-Neutralizing Antibodies Against SARS-CoV-2 Dependent on the Individual
    Li, Jin
    Zou, Li
    Li, Shaojie
    Zou, Ruogu
    Fang, Zhixiong
    Zhang, Pingan
    Li, Huijun
    Wang, Shanshan
    Ke, Dong
    Gao, Peng
    Jin, Cuicui
    Fang, Cong
    Zhou, Ji
    He, Ellen
    Skog, Sven
    VIRAL IMMUNOLOGY, 2023, 36 (03) : 153 - 162
  • [28] The development of a novel SARS-CoV-2 virus neutralizing immunotoxin
    Kostin, N.
    Bobik, T.
    Skryabin, G.
    Shulga, A.
    Smirnov, I.
    Deyev, S.
    Gabibov, A.
    FEBS OPEN BIO, 2022, 12 : 265 - 265
  • [29] Emerging Landscape of SARS-CoV-2 Variants and Detection Technologies
    Li, Xianghui
    Wang, Jing
    Geng, Jingping
    Xiao, Liming
    Wang, Hu
    MOLECULAR DIAGNOSIS & THERAPY, 2023, 27 (02) : 159 - 177
  • [30] Emerging Landscape of SARS-CoV-2 Variants and Detection Technologies
    Xianghui Li
    Jing Wang
    Jingping Geng
    Liming Xiao
    Hu Wang
    Molecular Diagnosis & Therapy, 2023, 27 : 159 - 177